Procurement Summary
Country: Ireland
Summary: Molecular Red Cell Genotyping (Qpcr-Based)
Deadline: 17 Apr 2026
Posting Date: 13 Mar 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 137709879
Document Ref. No.:
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
33124110 - Diagnostic systems
33124100 - Diagnostic devices
33694000 - Diagnostic agents
33141625 - Diagnostic kits
33194220 - Blood-transfusion supplies
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Molecular Red Cell Genotyping (qPCR-based)The Irish Blood Transfusion Service (IBTS) is undertaking a Preliminary Market Consultation (PMC) to gather information from suppliers regarding molecular red cell genotyping assays based on real-time PCR (qPCR) technology for use in a transfusion medicine laboratory.IBTS currently performs molecular testing for red cell antigen genotyping as part of its specialist immunohaematology services. As part of future planning, IBTS is exploring qPCR-based solutions for red cell genotyping that may provide reliable, efficient testing workflows suitable for routine laboratory use.Through this consultation, IBTS wishes to understand the range of commercially available assays or kits capable of detecting clinically relevant red cell blood group variants and alleles used in transfusion practice.Potential solutions should ideally:•Use real-time PCR technology compatible with standard laboratory qPCR instruments.•Detect clinically significant red cell antigen variants relevant to transfusion medicine.•Include appropriate reagents, controls, and analysis guidance to support reliable interpretation.•Be suitable for routine laboratory workflows and supported by appropriate technical documentation.
Procedure : Preliminary Market Consultation
Publication Date : 17/04/2026
Deadline : 17/04/2026 13:00:00
Documents
Tender Notice